A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China
Background. Hepatocellular carcinoma (HCC) is one of the major malignancies associated with high mortality rates. Chinese herbal medicine (CHM) alone, or in combination with conventional therapies (CT), has been widely used for patients with HCC in China. This study aims to explore how integrative t...
Main Authors: | Lingling Sun, Paul Fahey, Xiaoshu Zhu, Weng Ng, Zhuo Ping Chen, Yiwen Qiu, Hezheng Lai, Jietao Lin, Lizhu Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-09-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/1534735418775819 |
Similar Items
-
Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data
by: Lingling Sun, et al.
Published: (2019-01-01) -
Effect of Chinese Herbal Medicine on the Survival of Colorectal Cancer Patients With Liver-Limited Metastases: A Retrospective Cohort Study, 2008 to 2017
by: Cui Shao MD, et al.
Published: (2019-10-01) -
Herbal Medicine and Hepatocellular Carcinoma: Applications and Challenges
by: Yan Li, et al.
Published: (2011-01-01) -
Interactions between Herbal Medicinal Products and Conventional Drugs
by: Tomić, S., et al.
Published: (2011-06-01) -
Systematically investigation the effect of Chinese herbal medicines on Hepatocellular Carcinoma
by: Jia-An Chang, et al.
Published: (2016)